2008
DOI: 10.1186/1745-0179-4-21
|View full text |Cite
|
Sign up to set email alerts
|

Treating bipolar disorder in patients with renal failure having haemodialysis: two case reports

Abstract: BackgroundThere is little published guideline or evidence on treating bipolar affective disorder in patients with renal failure having haemodialysis.CaseWe present two patients with bipolar affective disorder with renal failure having haemodialysis. We used lorazepam in one patient to manage the immediate risk of non-engagement with dialysis. Risperidone was added in the second patient for managing psychotic symptoms. Valproate was started as a mood stabiliser and titrated upwards for long-term management of t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Contrary to this, in our study renal nurses probed patients with SMI to ascertain if they were in pain or feeling unwell due to infection and referred patients accordingly for medical treatment. Potential reasons for fluctuating mental capacity in patients with SMI receiving haemodialysis may be attributed to uraemia, infection and non-adherence with psychiatric medication (Gupta and Annadatha, 2008). This suggests that renal nurses may have more resilience than other nurses caring for patients with SMI due to their regular and on-going contact with patients.…”
Section: Discussionmentioning
confidence: 99%
“…Contrary to this, in our study renal nurses probed patients with SMI to ascertain if they were in pain or feeling unwell due to infection and referred patients accordingly for medical treatment. Potential reasons for fluctuating mental capacity in patients with SMI receiving haemodialysis may be attributed to uraemia, infection and non-adherence with psychiatric medication (Gupta and Annadatha, 2008). This suggests that renal nurses may have more resilience than other nurses caring for patients with SMI due to their regular and on-going contact with patients.…”
Section: Discussionmentioning
confidence: 99%
“…VPA is primarily metabolized by the liver; therefore, the management of the dose and blood level should be relatively easy because of its low dialyzability [ 15 ]. Therefore, VPA seems to be safe even for patients on hemodialysis.…”
Section: Case Presentationmentioning
confidence: 99%